EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus

OBJECTIVES: The objectives of this study were to investigate the discriminative ability of EQ-5D-3L full health state (FHS) in clinical trials of SLE, and to identify factors associated with FHS after treatment. METHODS: Data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials of belim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindblom, Julius, Gomez, Alvaro, Borg, Alexander, Emamikia, Sharzad, Ladakis, Dimitris , Matilla, Joaquin, Pehr, Martin, Cobar, Flordelyn, Enman, Yvonne, Heintz, Emelie , Regardt, Malin, Parodis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487305/
https://www.ncbi.nlm.nih.gov/pubmed/33502473
http://dx.doi.org/10.1093/rheumatology/keab080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487305/
https://www.ncbi.nlm.nih.gov/pubmed/33502473
http://dx.doi.org/10.1093/rheumatology/keab080

Ejemplares similares